Miller AH - Search Results

1

Tyrosine metabolism during interferon-alpha administration: association with fatigue and CSF dopamine concentrations.

Felger JC, Li L, Marvar PJ, Woolwine BJ, Harrison DG, Raison CL, Miller AH. Felger JC, et al. Among authors: miller ah. Brain Behav Immun. 2013 Jul;31:153-60. doi: 10.1016/j.bbi.2012.10.010. Epub 2012 Oct 13. Brain Behav Immun. 2013. PMID: 23072726 Free PMC article.

2

Double jeopardy: schizophrenia and substance use.

Swofford CD, Scheller-Gilkey G, Miller AH, Woolwine B, Mance R. Swofford CD, et al. Among authors: miller ah. Am J Drug Alcohol Abuse. 2000 Aug;26(3):343-53. doi: 10.1081/ada-100100248. Am J Drug Alcohol Abuse. 2000. PMID: 10976661

3

The neuroimmunology of stress and depression.

Raison CL, Miller AH. Raison CL, et al. Among authors: miller ah. Semin Clin Neuropsychiatry. 2001 Oct;6(4):277-94. doi: 10.1053/scnp.2001.0060277. Semin Clin Neuropsychiatry. 2001. PMID: 11607923

4

Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.

Capuron L, Gumnick JF, Musselman DL, Lawson DH, Reemsnyder A, Nemeroff CB, Miller AH. Capuron L, et al. Among authors: miller ah. Neuropsychopharmacology. 2002 May;26(5):643-52. doi: 10.1016/S0893-133X(01)00407-9. Neuropsychopharmacology. 2002. PMID: 11927189 Clinical Trial.

5

Treatment of cytokine-induced depression.

Capuron L, Hauser P, Hinze-Selch D, Miller AH, Neveu PJ. Capuron L, et al. Among authors: miller ah. Brain Behav Immun. 2002 Oct;16(5):575-80. doi: 10.1016/s0889-1591(02)00007-7. Brain Behav Immun. 2002. PMID: 12401471 Review.

6

Increased early life stress and depressive symptoms in patients with comorbid substance abuse and schizophrenia.

Scheller-Gilkey G, Thomas SM, Woolwine BJ, Miller AH. Scheller-Gilkey G, et al. Among authors: miller ah. Schizophr Bull. 2002;28(2):223-31. doi: 10.1093/oxfordjournals.schbul.a006933. Schizophr Bull. 2002. PMID: 12693429

7

Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy.

Capuron L, Raison CL, Musselman DL, Lawson DH, Nemeroff CB, Miller AH. Capuron L, et al. Among authors: miller ah. Am J Psychiatry. 2003 Jul;160(7):1342-5. doi: 10.1176/appi.ajp.160.7.1342. Am J Psychiatry. 2003. PMID: 12832253 Clinical Trial.

8

Depression in cancer: new developments regarding diagnosis and treatment.

Raison CL, Miller AH. Raison CL, et al. Among authors: miller ah. Biol Psychiatry. 2003 Aug 1;54(3):283-94. doi: 10.1016/s0006-3223(03)00413-x. Biol Psychiatry. 2003. PMID: 12893104 Review.

9

[Neuro-immune interactions in psychopathology with the example of interferon-alpha-induced depression].

Capuron L, Dantzer R, Miller AH. Capuron L, et al. Among authors: miller ah. J Soc Biol. 2003;197(2):151-6. J Soc Biol. 2003. PMID: 12910630 Review. French.

10

When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders.

Raison CL, Miller AH. Raison CL, et al. Among authors: miller ah. Am J Psychiatry. 2003 Sep;160(9):1554-65. doi: 10.1176/appi.ajp.160.9.1554. Am J Psychiatry. 2003. PMID: 12944327 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

404 results

Search Page

Filters